Buy Larsen and Toubro (L&T), says Sudarshan Sukhani of s2analytics.com.
Sukhani told CNBC-TV18, "L&T looks excellent, after the rally it's gone through a consolidation that consolidation seems to be getting out over today. So it's a blue chip. That's a stock I would look at seriously to buy and options are available on it. So not infrastructure as such, but something close by. L&T has the potential of being an outperformer in the near future. So L&T is a swing trading or a day trading instrument where you can go long in options, in futures and equity."
He further added, " Cipla in any case had the slightly indifferent charts and it was the least preferred of the 3-4 pharma companies at the top. So today it's reacted to the news. I think its best left alone. I won't say it's bearish, but there is nothing to buy here."
